Notify me when Steven Michael Oliveira files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Common Stock | 4.1% | $69,324 | -$788,375 | 161,218 | -92% | Oliveira Steven Michael | 01 Oct 2025 |
| FBRX | Forte Biosciences, Inc. | Common Stock, $0.001 par value | 2.4% | $6,797,265 | -$2,993,786 | 300,100 | -31% | Oliveira Steven Michael | 08 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|